{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:36:37Z","timestamp":1790660197771,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["GAUK 1600317"],"award-info":[{"award-number":["GAUK 1600317"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SVV 260412\/2017"],"award-info":[{"award-number":["SVV 260412\/2017"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SVV 260414\/2017"],"award-info":[{"award-number":["SVV 260414\/2017"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jpba.2017.06.071","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T17:01:01Z","timestamp":1499101261000},"page":"400-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Current antiviral drugs and their analysis in biological materials\u2014Part I: Antivirals against respiratory and herpes viruses"],"prefix":"10.1016","volume":"147","author":[{"given":"Lucie","family":"Nov\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Pavl\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Chrenkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Martinec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk\u00e1\u0161","family":"\u010cerven\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.06.071_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jpba.2017.06.071_bib0010","unstructured":"WHO, No Title (n.d.). http:\/\/www.who.int\/mediacentre\/factsheets\/fs400\/en\/ (Accessed 30 March 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0015","unstructured":"WHO, No Title (n.d.). http:\/\/www.who.int\/gho\/hiv\/en\/ (Accessed 30 March 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0020","unstructured":"WHO, No Title (n.d.). http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/ (Accessed 30 March 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0025","unstructured":"WHO, No Title (n.d.). http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ (Accessed 30 March 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0030","series-title":"State of the Art of Vaccine Research and Development","author":"World Health Organisation","year":"2006"},{"key":"10.1016\/j.jpba.2017.06.071_bib0035","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2017.06.071_bib0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2424","article-title":"The design of drugs for HIV and HCV","volume":"6","author":"De Clercq","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2017.06.071_bib0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/272583a0","article-title":"9-(2-Hydroxyethoxymethyl) guanine activity against viruses of the herpes group","volume":"272","author":"Schaeffer","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2017.06.071_bib0050","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1365-2036.2011.04869.x","article-title":"Review article: current antiviral therapy of chronic hepatitis B","volume":"34","author":"Ayoub","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.06.071_bib0055","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza","volume":"156","author":"Hsu","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM199609053351007","article-title":"Ganciclovir","volume":"335","author":"Crumpacker","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM199209103271108","article-title":"Acyclovir: a decade later","volume":"327","author":"Whitley","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0070","unstructured":"20th Edition WHO Model List of Essential Medicines (March 2017), http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/20th_EML2017.pdf?ua=1 (Accessed: 08.07.17)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0075","article-title":"Current antiviral drugs and their analysis in biological materials\u2014part II: antivirals against hepatitis and HIV viruses","author":"Nov\u00e1kov\u00e1","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chroma.2012.08.087","article-title":"Challenges in the development of bioanalytical liquid chromatography\u2013mass spectrometry method with emphasis on fast analysis","volume":"1292","author":"Nov\u00e1kov\u00e1","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.06.071_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2016.09.028","article-title":"Bioanalytical method development and validation: critical concepts and strategies","volume":"1043","author":"Moein","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpba.2015.03.007","article-title":"Supercritical fluid chromatography in pharmaceutical analysis","volume":"113","author":"Desfontaine","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0095","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.clinbiochem.2016.05.001","article-title":"LC\u2013MS\/MS as a tool for TDM services: where are we?","volume":"49","author":"Shipkova","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2017.06.071_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"Roberts","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1567201812666151029100909","article-title":"Consensus guideline based therapeutic drug monitoring (TDM) in psychiatry and neurology","volume":"13","author":"Hiemke","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jpba.2017.06.071_bib0110","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00216-010-3986-z","article-title":"Therapeutic drug monitoring by LC\u2013MS\u2013MS with special focus on anti-infective drugs","volume":"398","author":"M\u00fcller","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2017.06.071_bib0115","first-page":"9","article-title":"Advances in sample preparation for biological fluids","volume":"29","author":"Nov\u00e1kov\u00e1","year":"2016","journal-title":"LCGC Eur."},{"key":"10.1016\/j.jpba.2017.06.071_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2013.02.013","article-title":"Tracing and separating plasma components causing matrix effects in hydrophilic interaction chromatography\u2013electrospray ionization mass spectrometry","volume":"923\u2013924","author":"Ekdahl","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2009.10.004","article-title":"A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation","volume":"656","author":"Nov\u00e1kov\u00e1","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.06.071_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/bmc.1560","article-title":"Recent advances in sample preparation techniques for effective bioanalytical methods","volume":"25","author":"Kole","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2017.06.071_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpba.2013.03.012","article-title":"Importance of instrumentation for fast liquid chromatography in pharmaceutical analysis","volume":"87","author":"Fekete","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0140","series-title":"Supercrit. Fluid Chromatogr.","first-page":"461","article-title":"Pharmaceutical applications","author":"Nov\u00e1kov\u00e1","year":"2017"},{"key":"10.1016\/j.jpba.2017.06.071_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.aca.2014.03.034","article-title":"Modern analytical supercritical fluid chromatography using columns packed with sub-2\u03bcm particles: a tutorial","volume":"824","author":"Nov\u00e1kov\u00e1","year":"2014","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.06.071_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2011.09.041","article-title":"Therapeutic drug monitoring and LC\u2013MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2011.11.044","article-title":"The role of liquid chromatography\u2013tandem mass spectrometry in the clinical laboratory","volume":"883\u2013884","author":"van den Ouweland","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jms.1921","article-title":"It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS","volume":"46","author":"Ramanathan","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2017.06.071_bib0165","series-title":"Farmaceutick\u00e1 chemie IV","author":"Hartl","year":"2006"},{"key":"10.1016\/j.jpba.2017.06.071_bib0170","doi-asserted-by":"crossref","first-page":"e0141164","DOI":"10.1371\/journal.pone.0141164","article-title":"Potential for drug-drug interactions between antiretrovirals and HCV direct acting antivirals in a large cohort of HIV\/HCV coinfected patients","volume":"10","author":"Poizot-Martin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2017.06.071_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bcp.13095","article-title":"Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C","volume":"83","author":"Talavera Pons","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40121-015-0061-2","article-title":"Drug-drug interactions among hepatitis C virus (HCV) and human immunodeficiency virus (HIV) medications","volume":"4","author":"Kaur","year":"2015","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jpba.2017.06.071_bib0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug\u2013drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0190","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. (Accessed: 26.04.17)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0195","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.00650-15","article-title":"Development and validation of two screening assays for the hepatitis C Virus NS3 Q80K polymorphism associated with reduced response to combination treatment regimens containing simeprevir","volume":"53","author":"Chui","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0200","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7415","article-title":"Correlation between viral load of HBV in chronic hepatitis B patients and precore and basal core promoter mutations","volume":"13","author":"Ghabeshi","year":"2013","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.jpba.2017.06.071_bib0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(08)61115-0","article-title":"Relation between HIV viral load and infectiousness: a model-based analysis","volume":"372","author":"Wilson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2017.06.071_bib0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jiac.2015.11.002","article-title":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease","volume":"22","author":"Ito","year":"2016","journal-title":"J. Infect. Chemother."},{"issue":"Suppl. 2","key":"10.1016\/j.jpba.2017.06.071_bib0215","first-page":"65A","article-title":"Herpes simplex virus, meningitis and encephalitis in neonates","volume":"11","author":"Kimberlin","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.jpba.2017.06.071_bib0220","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella\u2013zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0225","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpba.2017.06.071_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study","volume":"27","author":"Stoelben","year":"2014","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jpba.2017.06.071_bib0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2017.06.071_bib0240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jpba.2017.06.071_bib0245","first-page":"CD002898","article-title":"Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis","volume":"12","author":"Wilhelmus","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpba.2017.06.071_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0706446","article-title":"Antiviral prodrugs \u2013 the development of successful prodrug strategies for antiviral chemotherapy","volume":"147","author":"De Clercq","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198902023200507","article-title":"Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome","volume":"320","author":"Chatis","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0260","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Case history: acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2017.06.071_bib0265","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of action of foscarnet against viral polymerases","volume":"92","author":"Crumpacker","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0270","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2004.07.039","article-title":"Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster","volume":"68","author":"De Clercq","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.jpba.2017.06.071_bib0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/02713689109020379","article-title":"Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents","volume":"10","author":"Maudgal","year":"1991","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jpba.2017.06.071_bib0280","unstructured":"European Centre for Disease Prevention and Control, Distribution of Antibacterials For Systemic Use (ATC group J01) in the community (primary care sector) in Austria, reporting year 2015 (n.d.). http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial-resistance-and-consumption\/antimicrobial-consumption\/esac-net-database\/Pages\/consumption-rates-by-country.aspx (Accessed 25 April 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0285","unstructured":"https:\/\/chemicalize.com\/ (Accessed April 25 2017)."},{"key":"10.1016\/j.jpba.2017.06.071_bib0290","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.jchromb.2011.09.031","article-title":"Development of a liquid chromatography\u2013tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants","volume":"879","author":"Cohen-Wolkowiez","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jchromb.2010.12.033","article-title":"Determination of Ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography-tandem mass spectrometry","volume":"879","author":"Heinig","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0300","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jchromb.2008.01.046","article-title":"Selective and rapid liquid chromatography\/negative-ion electrospray ionization mass spectrometry method for the quantification of valacyclovir and its metabolite in human plasma","volume":"864","author":"Kasiari","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jchromb.2006.10.053","article-title":"A Sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC\/MS\/MS","volume":"848","author":"Xu","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tvjl.2014.11.011","article-title":"Clinical and antiviral effect of a single oral dose of famciclovir administered to cats at intake to a shelter","volume":"203","author":"Litster","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.jpba.2017.06.071_bib0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jchromb.2007.01.044","article-title":"Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study","volume":"852","author":"Lee","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jchromb.2008.04.022","article-title":"Simultaneous determination of aciclovir, ganciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"867","author":"Dao","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0325","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jchromb.2007.01.045","article-title":"Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples","volume":"852","author":"Perrottet","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0330","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clinbiochem.2011.12.014","article-title":"Determination of ganciclovir in human plasma by ultra performance liquid chromatography-UV detection","volume":"45","author":"Padull\u00e9s","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2017.06.071_bib0335","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cca.2013.09.049","article-title":"Measurement of ganciclovir concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"427","author":"Rigo-Bonnin","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.06.071_bib0340","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.chroma.2014.04.045","article-title":"Hybrid molecularly imprinted polymers synthesized with 3-aminopropyltriethoxysilane-methacrylic acid monomer for miniaturized solid-phase extraction: a new and economical sample preparation strategy for determination of acyclovir in urine","volume":"1346","author":"Yan","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.06.071_bib0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2009.02.010","article-title":"Vitreous penetration of orally administered famciclovir","volume":"148","author":"Chong","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0350","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jchromb.2010.07.008","article-title":"Analysis of the antiviral drugs acyclovir and valacyclovir-hydrochloride in tsetse flies (Glossina pallidipes) using LC\u2013MSMS","volume":"878","author":"Sasanya","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rvsc.2016.03.021","article-title":"Topical distribution of acyclovir in normal equine skin and equine sarcoids: an in vitro study","volume":"106","author":"Haspeslagh","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0360","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.clinbiochem.2011.04.003","article-title":"Determination of valganciclovir and ganciclovir in human plasma by liquid chromatography tandem mass spectrometric detection","volume":"44","author":"Singh","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2017.06.071_bib0365","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jchromb.2009.01.042","article-title":"Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography\u2013tandem mass spectrometry method","volume":"877","author":"Yadav","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.06.071_bib0370","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.etap.2016.07.018","article-title":"A metabolic profiling analysis of the nephrotoxicity of acyclovir in rats using ultra performance liquid chromatography\/mass spectrometry","volume":"46","author":"Xing","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0375","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.colsurfb.2015.10.045","article-title":"Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir","volume":"136","author":"Al-Dhubiab","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jpba.2017.06.071_bib0380","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1734-1140(13)71026-0","article-title":"Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3","volume":"65","author":"Ye","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpba.2017.06.071_bib0385","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jpba.2017.06.071_bib0390","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tim.2013.05.005","article-title":"Interspecies transmission and emergence of novel viruses: lessons from bats and birds","volume":"21","author":"Chan","year":"2013","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0395","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","article-title":"Avian influenza virus (H5N1): a threat to human health","volume":"20","author":"Peiris","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jpba.2017.06.071_bib0400","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijporl.2011.09.029","article-title":"Risk of acute otitis media in relation to acute bronchiolitis in children","volume":"76","author":"Gomaa","year":"2012","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0405","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/095632020201300601","article-title":"The quest for an efficacious antiviral for respiratory syncytial virus","volume":"13","author":"Torrence","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jpba.2017.06.071_bib0410","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jmb.2008.11.022","article-title":"Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding","volume":"385","author":"Cady","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jpba.2017.06.071_bib0415","article-title":"Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation","volume":"13","author":"Tappenden","year":"2009","journal-title":"Health Technol. Assess. (Rockv.)"},{"key":"10.1016\/j.jpba.2017.06.071_bib0420","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-014-1629-z","article-title":"Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma","volume":"465","author":"Alves","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jpba.2017.06.071_bib0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/095632020501600302","article-title":"Achievements and challenges in antiviral drug discovery","volume":"16","author":"Littler","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jpba.2017.06.071_bib0430","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (Tamiflu(R)) and its potential for use in the event of an influenza pandemic","volume":"55","author":"Ward","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2017.06.071_bib0435","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-151-7-200910060-00143","article-title":"Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza","volume":"151","author":"Khazeni","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jpba.2017.06.071_bib0440","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/589748","article-title":"Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children","volume":"47","author":"Sugaya","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2017.06.071_bib0445","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/v7092850","article-title":"Clinical implications of antiviral resistance in influenza","volume":"7","author":"Li","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jpba.2017.06.071_bib0450","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral drugs for viruses other than human immunodeficiency virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jpba.2017.06.071_bib0455","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0460","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1002\/jps.24375","article-title":"Synthesis and evaluation of bile acid-ribavirin conjugates as prodrugs to target the liver","volume":"104","author":"Dong","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0465","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpba.2012.03.030","article-title":"Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients","volume":"66","author":"D\u2019Avolio","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0470","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cca.2011.07.016","article-title":"LC-MS\/MS quantitation of ribavirin in serum and identification of endogenous isobaric interferences","volume":"412","author":"Danso","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.06.071_bib0475","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpba.2012.08.029","article-title":"Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionizat","volume":"72","author":"Hu","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0480","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2885.2011.01278.x","article-title":"Pharmacokinetics of amantadine in cats","volume":"34","author":"Siao","year":"2011","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.06.071_bib0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2008.01.053","article-title":"Determination of rimantadine in rat plasma by liquid chromatography\/electrospray mass spectrometry and its application in a pharmacokinetic study","volume":"864","author":"Xu","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0490","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2006.08.014","article-title":"Simultaneous determination of ribavirin and ribavirin base in monkey plasma by high performance liquid chromatography with tandem mass spectrometry","volume":"846","author":"Li","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0495","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2012.02.026","article-title":"Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"891\u2013892","author":"Kromdijk","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0500","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.talanta.2011.11.004","article-title":"Determination of ribavirin in human serum using liquid chromatography tandem mass spectrometry","volume":"88","author":"van der Lijke","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2017.06.071_bib0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jchromb.2014.11.032","article-title":"Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS\/MS quantification","volume":"978\u2013979","author":"Jimmerson","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0510","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpha.2012.11.004","article-title":"Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LC-MS\/MS to support a bioequivalence study","volume":"3","author":"Gupta","year":"2013","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0515","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1002\/jps.22627","article-title":"Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers","volume":"100","author":"Morimoto","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0520","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jchromb.2008.01.048","article-title":"Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performance liquid chromatography with UV detection","volume":"864","author":"Bahrami","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0525","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2007.09.018","article-title":"Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine","volume":"859","author":"Lindeg\u00e5rdh","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0530","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchromb.2007.05.039","article-title":"Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection","volume":"856","author":"Loregian","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0535","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jpba.2006.09.001","article-title":"LC-MS\/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells","volume":"43","author":"Yeh","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0540","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jchromb.2008.10.037","article-title":"Sensitive determination of oseltamivir and oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and brain by liquid chromatography-tandem mass spectrometry","volume":"876","author":"Heinig","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0545","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jpba.2006.10.044","article-title":"Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study","volume":"43","author":"Wang","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.06.071_bib0550","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2013.10.035","article-title":"Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry","volume":"944","author":"Jimmerson","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.06.071_bib0555","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ajog.2011.03.002","article-title":"Pharmacokinetics of oseltamivir among pregnant and nonpregnant women","volume":"204","author":"Beigi","year":"2011","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517312050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517312050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T04:01:14Z","timestamp":1656734474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517312050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":111,"alternative-id":["S0731708517312050"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.06.071","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current antiviral drugs and their analysis in biological materials\u2014Part I: Antivirals against respiratory and herpes viruses","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.06.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}